ReviewBiomedicines2022
PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas.
Wei Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papertrialcites it
ReviewBiomedicines2022
Wei Xie et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.